San Rafael, CA, United States of America

Michel Claude Vellard

This inventor holds 16 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 9 EPO patents. Top assignee: Biomarin Pharmaceutical Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Claude Vellard. Retrieved from https://idiyas.com/inventor/michel-claude-vellard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 264(Granted Patents)


Location History:

  • Larkspur, CA (US) (2009)
  • Corte Madera, CA (US) (2009)
  • Novato, CA (US) (2020 - 2021)
  • San Rafael, CA (US) (2009 - 2022)

Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Mind of Michel Claude Vellard

Introduction

Michel Claude Vellard is an accomplished inventor based in San Rafael, CA, who has made significant contributions to the field of biochemistry. With a remarkable portfolio of 16 patents, Vellard’s work primarily focuses on the development of enzymes that have substantial therapeutic and industrial applications.

Latest Patents

Among his latest innovations, Vellard has developed a patent for the manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and their uses. This invention encompasses compositions of these enzymes, methods for their production and purification, and their applications in diagnosing and treating lysosomal storage diseases caused by deficiencies in the sulfatase enzyme.

Another recent patent involves compositions of prokaryotic phenylalanine ammonia-lyase (PAL) variants and methods of utilizing these compositions. This invention presents PAL variants produced by prokaryotes that exhibit enhanced phenylalanine-converting activity and reduced immunogenicity compared to traditional PAL. These innovations hold promise for treating conditions like hyperphenylalaninemia, including phenylketonuria, and potentially even cancer.

Career Highlights

Vellard’s career is marked by significant achievements in the pharmaceutical industry, particularly during his tenure at BioMarin Pharmaceutical Inc. His work showcases his commitment to medical advancements and improving treatment options for patients suffering from genetic disorders.

Collaborations

Throughout his career, Michel Claude Vellard has collaborated with notable colleagues, including Augustus O. Okhamafe and Daniel J. Wendt. These partnerships have contributed to the innovative nature of his research and development efforts, underscoring the collaborative spirit within the scientific community.

Conclusion

Michel Claude Vellard continues to be a pivotal figure in the realm of biochemistry and enzyme technology. His patents not only enhance our understanding of enzymatic functions but also pave the way for novel therapeutic strategies. As he progresses in his career, the impact of his innovations is likely to resonate throughout the biomedical field and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…